Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Ophthotech Appoints CFO

This article was originally published in Scrip

Executive Summary

Ophthotech Corporation has appointed Glenn P. Sblendorio executive vice president, chief operating officer and chief financial officer (CFO) – effective April 1, 2016. The company also announced that the current executive vice president and chief financial and business officer, Michael G. Atieh will be retiring – effective April 1, 2016. Sblendorio will be joining Ophthotech from The Medicines Company, where he most recently served as president and CFO. Previously he held various senior management positions at Hoffmann-La Roche, Inc., Eyetech Pharmaceuticals Inc. and MPM Capital Advisors, LLC.

Advertisement
Advertisement
UsernamePublicRestriction

Register